ADMS - Adamas Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5172.92M
Enterprise Value 380.63M
Trailing P/E N/A
Forward P/E 1-2.50
PEG Ratio (5 yr expected) 1-0.09
Price/Sales (ttm)5.08
Price/Book (mrq)1.92
Enterprise Value/Revenue 32.37
Enterprise Value/EBITDA 6-0.71

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018


Profit Margin 0.00%
Operating Margin (ttm)-337.85%

Management Effectiveness

Return on Assets (ttm)-34.15%
Return on Equity (ttm)-167.94%

Income Statement

Revenue (ttm)34.05M
Revenue Per Share (ttm)1.27
Quarterly Revenue Growth (yoy)2,244.20%
Gross Profit (ttm)N/A
EBITDA -113.56M
Net Income Avi to Common (ttm)-131M
Diluted EPS (ttm)-4.87
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)210.87M
Total Cash Per Share (mrq)7.68
Total Debt (mrq)119.12M
Total Debt/Equity (mrq)132.53
Current Ratio (mrq)9.41
Book Value Per Share (mrq)3.28

Cash Flow Statement

Operating Cash Flow (ttm)-104.22M
Levered Free Cash Flow (ttm)-73.4M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.25
52-Week Change 3-77.41%
S&P500 52-Week Change 311.35%
52 Week High 332.90
52 Week Low 36.15
50-Day Moving Average 37.21
200-Day Moving Average 310.21

Share Statistics

Avg Vol (3 month) 3577.73k
Avg Vol (10 day) 3276.77k
Shares Outstanding 527.45M
Float 16.64M
% Held by Insiders 12.11%
% Held by Institutions 1114.84%
Shares Short (Mar 29, 2019) 46.66M
Short Ratio (Mar 29, 2019) 47.35
Short % of Float (Mar 29, 2019) 4N/A
Short % of Shares Outstanding (Mar 29, 2019) 424.27%
Shares Short (prior month Feb 28, 2019) 45.75M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A